Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Clinical trial NCT01116648 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01116648
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Ovarian Endometrioid Adenocarcinoma Ovarian High Grade Serous Adenocarcinoma Ovarian Serous Adenocarcinoma Ovarian Serous Surface Papillary Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma Triple-Negative Breast Carcinoma

Start date: 2010-04-14
Primary completion: 2018-10-31
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.